In the ADAURA trial, a subgroup analysis showed a trend toward worse OS in male patients (HR, 0.62; 95% CI, 0.33–1.13) compared with that in female patients (HR, 0.41; 95% CI, 0.25–0.66) [ 6 ].
← all excerpts
Prognostic Impact of Postoperative Recurrence in Patients With Epidermal Growth Factor Receptor-Positive Non-Small Cell Lung Cancer.
1
—
—